Short- and Long-Term Outcomes for Extremely Preterm Infants

American Journal of Perinatology

Volumn 33, Issue 3, 2016, Pages 318-328

  Patel, Ravi Mangal ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

low birth weight; morbidity; neurodevelopment; periviable; prematurity; survival

Indexed keywords

BEVACIZUMAB; CAFFEINE; CORTICOSTEROID; DEXAMETHASONE; INDOMETACIN; LUNG SURFACTANT; PLACEBO; PROBIOTIC AGENT; RETINOL;

AGE SPECIFIC CARE; BRAIN HEMORRHAGE; BRAIN INJURY; CAUSE OF DEATH; CEREBRAL PALSY; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; ENCEPHALOMALACIA; EXTREMELY LOW BIRTH WEIGHT; FAMILY COUNSELING; GESTATIONAL AGE; HUMAN; INFANT; INFANT MORTALITY; INFECTION; LUNG DYSPLASIA; MENTAL DISEASE; MOTOR DYSFUNCTION; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUROLOGIC DISEASE; NEWBORN CARE; NEWBORN MORBIDITY; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RESUSCITATION; RETROLENTAL FIBROPLASIA; REVIEW; SURVIVAL RATE; CLASSIFICATION; FEMALE; GROWTH, DEVELOPMENT AND AGING; INFANT, PREMATURE, DISEASES; MORTALITY; NEWBORN; QUALITY OF LIFE; TREATMENT OUTCOME;

FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84959159025     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1571202     Document Type: Review

References (95)

1. Blencowe H., Cousens S., Oestergaard M. Z., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet: 2012; 379 9832 2162 2172
2. Martin J. A., Hamilton B. E., Osterman M. JK. Births: final data for 2013. In: National Vital Statistics Reports. Vol 64. no 1. Hyattsville, MD National Center for Health Statistics: 2015
3. Mathews T. J., MacDorman M. F., Thoma M. E. Infant mortality statistics from the 2013 period linked birth/infant death data set. In: National Vital Statistics Reports. Vol 64 no 9. Hyattsville, MD National Center for Health Statistics: 2015
4. Stoll B. J., Hansen N. I., Bell E. F., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA: 2015; 314 10 1039 1051
5. Patel R. M., Kandefer S., Walsh M. C., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med: 2015; 372 4 331 340
6. Horbar J. D., Carpenter J. H., Badger G. J., et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics: 2012; 129 6 1019 1026
7. Ancel P. Y., Goffinet F., Kuhn P., et al. EPIPAGE-2 Writing Group. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr: 2015; 169 3 230 238
8. Shah P. S., Sankaran K., Aziz K., et al. Canadian Neonatal Network. Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern? J Perinatol: 2012; 32 2 132 138
9. Kusuda S., Fujimura M., Uchiyama A., Totsu S., Matsunami K.; Neonatal Research Network, Japan. Trends in morbidity and mortality among very-low-birth-weight infants from 2003 to 2008 in Japan. Pediatr Res: 2012; 72 5 531 538
10. Ishii N., Kono Y., Yonemoto N., Kusuda S., Fujimura M.; Neonatal Research Network, Japan. Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics: 2013; 132 1 62 71
11. Su B. H., Hsieh W. S., Hsu C. H., Chang J. H., Lien R., Lin C. H.; Premature Baby Foundation of Taiwan (PBFT). Neonatal outcomes of extremely preterm infants from taiwan: comparison with Canada, Japan, and the USA. Pediatr Neonatol: 2015; 56 1 46 52
12. Costeloe K. L., Hennessy E. M., Haider S., Stacey F., Marlow N., Draper E. S. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ: 2012; 345 e7976
13. Fellman V., Hellström-Westas L., Norman M., et al. EXPRESS Group. One-year survival of extremely preterm infants after active perinatal care in Sweden. JAMA: 2009; 301 21 2225 2233
14. Agarwal P., Sriram B., Rajadurai V. S. Neonatal outcome of extremely preterm Asian infants ©28 weeks over a decade in the new millennium. J Perinatol: 2015; 35 4 297 303
15. Guillen U., DeMauro S., Ma L., et al. Survival rates in extremely low birthweight infants depend on the denominator: avoiding potential for bias by specifying denominators. Am J Obstet Gynecol: 2011; 205 4 329.e1 329.e7
16. Shah P. S., Lee S. K., Lui K., et al. International Network for Evaluating Outcomes of Neonates (iNeo). The International Network for Evaluating Outcomes of very low birth weight, very preterm neonates (iNeo): a protocol for collaborative comparisons of international health services for quality improvement in neonatal care. BMC Pediatr: 2014; 14 110
17. Rysavy M. A., Li L., Bell E. F., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Between-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med: 2015; 372 19 1801 1811
18. Ecker J. L., Kaimal A., Mercer B. M., et al. American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine. #3: Periviable birth. Am J Obstet Gynecol: 2015; 213 5 604 614
19. Ward Platt M. The MBRRACE-UK perinatal surveillance report. Arch Dis Child Fetal Neonatal Ed: 2016; Jan; 101 1 4 5
20. Ahle M., Drott P., Andersson R. E. Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987-2009. Pediatrics: 2013; 132 2 e443 e451
21. Berrington J. E., Hearn R. I., Bythell M., Wright C., Embleton N. D. Deaths in preterm infants: changing pathology over 2 decades. J Pediatr: 2012; 160 1 49 53.e1
22. Jacob J., Kamitsuka M., Clark R. H., Kelleher A. S., Spitzer A. R. Etiologies of NICU deaths. Pediatrics: 2015; 135 1 e59 e65
23. Schmidt B., Roberts R. S., Davis P. G., et al. Caffeine for Apnea of Prematurity (CAP) Trial Investigators; Caffeine for Apnea of Prematurity CAP Trial Investigators. Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants. J Pediatr: 2015; 167 5 982 986.e2
24. Avery M. E., Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child: 1959; 97 (5, Pt 1): 517 523
25. Fujiwara T., Maeta H., Chida S., Morita T., Watabe Y., Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet: 1980; 1 8159 55 59
26. Stoll B. J., Hansen N. I., Bell E. F., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics: 2010; 126 3 443 456
27. Polin R. A., Carlo W. A.; Committee on Fetus and Newborn; American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics: 2014; 133 1 156 163
28. Bahadue F. L., Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev: 2012; 11 CD001456
29. Stevens T. P., Finer N. N., Carlo W. A., et al. SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr: 2014; 165 2 240 249.e4
30. Wyllie J., Perlman J. M., Kattwinkel J., et al. Neonatal Resuscitation Chapter Collaborators. Part 7: Neonatal resuscitation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation: 2015; 95 e169 e201
31. Northway W. H. Jr, Rosan R. C., Porter D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med: 1967; 276 7 357 368
32. Baraldi E., Filippone M. Chronic lung disease after premature birth. N Engl J Med: 2007; 357 19 1946 1955
33. Northway W. H. Jr, Moss R. B., Carlisle K. B., et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med: 1990; 323 26 1793 1799
34. Schmidt B., Roberts R. S., Davis P., et al. Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med: 2006; 354 20 2112 2121
35. Schmidt B., Anderson P. J., Doyle L. W., et al. Caffeine for Apnea of Prematurity (CAP) Trial Investigators. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA: 2012; 307 3 275 282
36. Tyson J. E., Wright L. L., Oh W., et al. National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med: 1999; 340 25 1962 1968
37. Doyle L. W., Ehrenkranz R. A., Halliday H. L. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev: 2014; 5 CD001145
38. Committee on Fetus and Newborn Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics: 2002; 109 2 330 338
39. Bassler D., Plavka R., Shinwell E. S., et al. NEUROSIS Trial Group. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N Engl J Med: 2015; 373 16 1497 1506
40. Patel R. M., Leong T., Carlton D. P., Vyas-Read S. Early caffeine therapy and clinical outcomes in extremely preterm infants. J Perinatol: 2013; 33 2 134 140
41. Dobson N. R., Patel R. M., Smith P. B., et al. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr: 2014; 164 5 992 998.e3
42. Lodha A., Seshia M., McMillan D. D., et al. Canadian Neonatal Network. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr: 2015; 169 1 33 38
43. Dykes F. D., Lazzara A., Ahmann P., Blumenstein B., Schwartz J., Brann A. W. Intraventricular hemorrhage: a prospective evaluation of etiopathogenesis. Pediatrics: 1980; 66 1 42 49
44. Evans N., Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed: 1996; 75 3 F183 F186
45. Schena F., Francescato G., Cappelleri A., et al. Association between hemodynamically significant patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr: 2015; 166 6 1488 1492
46. Dudell G. G., Gersony W. M. Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr: 1984; 104 6 915 920
47. Noori S., McCoy M., Friedlich P., et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics: 2009; 123 1 e138 e144
48. Rozé J. C., Cambonie G., Marchand-Martin L., et al. Hemodynamic EPIPAGE 2 Study Group. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants. JAMA: 2015; 313 24 2441 2448
49. Mirea L., Sankaran K., Seshia M., et al. Canadian Neonatal Network. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr: 2012; 161 4 689 94.e1
50. Schmidt B., Davis P., Moddemann D., et al. Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med: 2001; 344 26 1966 1972
51. Bose C. L., Laughon M. M. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed: 2007; 92 6 F498 F502
52. Stoll B. J., Hansen N., Fanaroff A. A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics: 2002; 110 2, Pt 1 285 291
53. Stoll B. J., Hansen N. I., Sánchez P. J., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics: 2011; 127 5 817 826
54. Stoll B. J., Hansen N. I., Adams-Chapman I., et al. National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA: 2004; 292 19 2357 2365
55. Adams-Chapman I., Bann C. M., Das A., et al. Eunice Kennedy Shriver National Institutes of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr: 2013; 163 4 961 7.e3
56. Benjamin D. K. Jr, Hudak M. L., Duara S., et al. Fluconazole Prophylaxis Study Team. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA: 2014; 311 17 1742 1749
57. Aliaga S., Clark R. H., Laughon M., et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics: 2014; 133 2 236 242
58. Fitzgibbons S. C., Ching Y., Yu D., et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg: 2009; 44 6 1072 1075, discussion 1075-1076
59. Hintz S. R., Kendrick D. E., Stoll B. J., et al. NICHD Neonatal Research Network. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics: 2005; 115 3 696 703
60. Grave G. D., Nelson S. A., Walker W. A., et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res: 2007; 62 4 510 514
61. Patel R. M., Denning P. W. Intestinal microbiota and its relationship with necrotizing enterocolitis. Pediatr Res: 2015; 78 3 232 238
62. Lucas A., Cole T. J. Breast milk and neonatal necrotising enterocolitis. Lancet: 1990; 336 8730 1519 1523
63. Cristofalo E. A., Schanler R. J., Blanco C. L., et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr: 2013; 163 6 1592 1595.e1
64. AlFaleh K., Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev: 2014; 4 CD005496
65. Terrin G., Passariello A., De Curtis M., et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics: 2012; 129 1 e40 e45
66. Kuppala V. S., Meinzen-Derr J., Morrow A. L., Schibler K. R. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr: 2011; 159 5 720 725
67. Cotten C. M., Taylor S., Stoll B., et al. NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics: 2009; 123 1 58 66
68. Chen J., Smith L. E. Retinopathy of prematurity. Angiogenesis: 2007; 10 2 133 140
69. Stenson B. J., Tarnow-Mordi W. O., Darlow B. A., et al. BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group. Oxygen saturation and outcomes in preterm infants. N Engl J Med: 2013; 368 22 2094 2104
70. Carlo W. A., Finer N. N., Walsh M. C., et al. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med: 2010; 362 21 1959 1969
71. Manley B. J., Kuschel C. A., Elder J. E., Doyle L. W., Davis P. G. Higher rates of retinopathy of prematurity after increasing oxygen saturation targets for very preterm infants: experience in a single center. J Pediatr: 2015; (e-pub ahead of print). doi:10.1016/j.jpeds.2015.10.005
72. Mintz-Hittner H. A., Kennedy K. A., Chuang A. Z.; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med: 2011; 364 7 603 615
73. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics: 2000; 105 2 295 310
74. L. Orton J., McGinley J. L., Fox L. M., Spittle A. J. Challenges of neurodevelopmental follow-up for extremely preterm infants at two years. Early Hum Dev: 2015; 91 12 689 694
75. Vohr B. R., Stephens B. E., Higgins R. D., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes. J Pediatr: 2012; 161 2 222 8.e3
76. Schlapbach L. J., Adams M., Proietti E., et al. Swiss Neonatal Network & Follow-up Group. Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. BMC Pediatr: 2012; 12 198
77. Moore T., Hennessy E. M., Myles J., et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ: 2012; 345 e7961
78. Anderson P. J., De Luca C. R., Hutchinson E., Roberts G., Doyle L. W.; Victorian Infant Collaborative Group. Underestimation of developmental delay by the new Bayley-III scale. Arch Pediatr Adolesc Med: 2010; 164 4 352 356
79. Spencer-Smith M. M., Spittle A. J., Lee K. J., Doyle L. W., Anderson P. J. Bayley-III cognitive and language scales in preterm children. Pediatrics: 2015; 135 5 e1258 e1265
80. Manley B. J., Roberts R. S., Doyle L. W., et al. Caffeine for Apnea of Prematurity (CAP) Trial Investigators; Caffeine for Apnea of Prematurity CAP Trial Investigators. Social variables predict gains in cognitive scores across the preschool years in children with birth weights 500 to 1250 grams. J Pediatr: 2015; 166 4 870 876.e1-2
81. Marlow N., Wolke D., Bracewell M. A., Samara M.; EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med: 2005; 352 1 9 19
82. Serenius F., Källén K., Blennow M., et al. EXPRESS Group. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA: 2013; 309 17 1810 1820
83. Beaino G., Khoshnood B., Kaminski M., et al. EPIPAGE Study Group. Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study. Dev Med Child Neurol: 2010; 52 6 e119 e125
84. Duncan A. F., Bann C., Boatman C., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Do currently recommended Bayley-III cutoffs overestimate motor impairment in infants born <27 weeks gestation? J Perinatol: 2015; 35 7 516 521
85. Poole K. L., Schmidt L. A., Missiuna C., Saigal S., Boyle M. H., Van Lieshout R. J. Motor coordination difficulties in extremely low birth weight survivors across four decades. J Dev Behav Pediatr: 2015; 36 7 521 528
86. Payne A. H., Hintz S. R., Hibbs A. M., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage. JAMA Pediatr: 2013; 167 5 451 459
87. Bolisetty S., Dhawan A., Abdel-Latif M., Bajuk B., Stack J., Lui K.; New South Wales and Australian Capital Territory Neonatal Intensive Care Units' Data Collection. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics: 2014; 133 1 55 62
88. Hintz S. R., Barnes P. D., Bulas D., et al. SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neuroimaging and neurodevelopmental outcome in extremely preterm infants. Pediatrics: 2015; 135 1 e32 e42
89. Woodward L. J., Anderson P. J., Austin N. C., Howard K., Inder T. E. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med: 2006; 355 7 685 694
90. Graham M., Levene M. I., Trounce J. Q., Rutter N. Prediction of cerebral palsy in very low birthweight infants: prospective ultrasound study. Lancet: 1987; 2 8559 593 596
91. Adams-Chapman I., Hansen N. I., Stoll B. J., Higgins R.; NICHD Research Network. Neurodevelopmental outcome of extremely low birth weight infants with posthemorrhagic hydrocephalus requiring shunt insertion. Pediatrics: 2008; 121 5 e1167 e1177
92. Saigal S. Quality of life of former premature infants during adolescence and beyond. Early Hum Dev: 2013; 89 4 209 213
93. Zwicker J. G., Harris S. R. Quality of life of formerly preterm and very low birth weight infants from preschool age to adulthood: a systematic review. Pediatrics: 2008; 121 2 e366 e376
94. Kim U. O., Basir M. A. Informing and educating parents about the risks and outcomes of prematurity. Clin Perinatol: 2014; 41 4 979 991
95. Guillén Ú, Suh S., Munson D., et al. Development and pretesting of a decision-aid to use when counseling parents facing imminent extreme premature delivery. J Pediatr: 2012; 160 3 382 387